Latest Market Access News

Amplia Therapeutics reports encouraging clinical progress for its pancreatic cancer drug narmafotinib, with a 35% confirmed response rate in the ACCENT trial and FDA support for dose optimisation. The company also uplisted to the US OTCQB market and secured a key patent extending protection to 2040.

Murray Cod Australia Ltd reported a robust 61% increase in sales volume and secured key certifications in Q2 FY26, while navigating operational challenges and expanding its distribution footprint.

Sun Silver Limited has reported a substantial 59 million ounce silver equivalent increase in its Maverick Springs mineral resource, now totalling 539Moz AgEq, alongside commencing U.S. OTCQX trading and appointing a strategic advisor to boost U.S. government engagement.

Avecho Biotechnology is on the cusp of completing patient dosing in its pivotal Phase III CBD insomnia trial, backed by a recent $2.5 million capital raise and patent allowances in the US and Europe.

HyTerra Limited has unveiled a comprehensive strategic plan to commercialise its Nemaha Project in Kansas, backed by new leadership and a key US technology partnership. The company is advancing towards production testing in 2026 amid promising hydrogen and helium discoveries.

Diablo Resources reports significant exploration advances at its Star Range silver-antimony and Phoenix copper projects in Utah, backed by a $2 million capital raise and new OTCQB listing to boost U.S. investor access.

Pinnacle Minerals has advanced its strategic pivot to North American critical minerals exploration, initiating fieldwork across multiple US projects and securing a strong cash position of approximately A$2.8 million.

Pantera Minerals has completed a $40 million divestment of its Smackover Lithium Project, pivoting strategically into U.S. critical minerals with a major land acquisition in Arkansas. The company’s strengthened balance sheet and expanded U.S. market presence set the stage for accelerated growth.

American Uranium Limited has reported significant progress at its Lo Herma ISR uranium project, completing extensive drilling and validating aquifer conditions that support in-situ recovery mining. The company is poised to update its resource estimates and advance development plans in 2026.

Volt Resources has made significant strides in its US graphite refinery project and secured major funding for its Bunyu Graphite Mine in Tanzania, positioning itself strongly in the critical minerals sector.

Bioxyne Limited has reported a record $17.2 million in quarterly revenue, driven by strong growth in its cannabis and psychedelics segments, alongside strategic international expansions including a Frankfurt dual listing and new manufacturing agreements.

Energy Transition Minerals Ltd (ETM) reported key progress in its December 2025 quarter, including legal developments for its Greenland rare earth project, advancing a strategic mine acquisition in Spain, and moves toward a US Nasdaq listing.